Achieve Life Sciences, Inc.
ACHV
$4.69
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.42% | -50.31% | -97.52% | -125.71% | -76.03% |
| Total Depreciation and Amortization | -5.26% | -3.51% | 8.77% | 1.75% | -1.72% |
| Total Amortization of Deferred Charges | 355.56% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.06% | 52.33% | 27.71% | 71.70% | -0.47% |
| Change in Net Operating Assets | 249.12% | -60.47% | 1.49% | 1,937.68% | 8,450.00% |
| Cash from Operations | -9.25% | -84.29% | -109.68% | -110.56% | -101.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -195.35% | 114.39% | -- | -- | -- |
| Cash from Investing | -195.35% | 114.39% | -- | 195,383.33% | 88,573.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,108.74% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 149.83% | 27,042.48% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -200.00% | -- | -- | 66.67% | 200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -282.66% | 175.24% | -99.48% | 173.38% | -1.16% |